Expression and Clinical Significance of Sperm-Associated Antigen 9 in Patients with Cervical Cancer and Cervical Intraepithelial Neoplasia

ZHANG Lu,YAN Lei,ZHANG Hui,ZHANG Xiaohui,LI Mingjiang,ZHAO Xingbo
DOI: https://doi.org/10.6040/j.issn.1671-7554.0.2014.062
2014-01-01
Abstract:Objective To investigate the clinical significance of sperm-associated antigen 9 ( SPAG9) in cervical cancer and cervical intraepithelial neoplasia ( CIN) patients.Methods The expressions of SPAG9 mRNA and protein were evaluated in cervical carcinoma (cervical carcinoma group, n=40), CIN (CIN group, n=35) and normal cervical tis-sues ( the control group, n=20) by immunohistochemistry, RT-PCR, and Western blotting.SPAG9 concentrations in serum samples from 10 healthy women, 20 women with hysteromyoma, 40 women with CIN, 40 women with cervical carcinoma, and 20 postoperative cervical carcinoma patients were detected by enzyme-linked immunosorbent assay ( ELISA) .Results ①The expression of SPAG9 was gradually increased in the control group, CIN group and cervical carcinomas group (all P<0.05);②A significant difference has been found between cervical carcinoma group and the control group by RT-PCR and Western blotting (P<0.05);③SPAG9 serum concentrations in cervical carcinoma pa-tients was significantly higher than those in the CIN and hysteromyoma patients and the healthy women (P<0.05). Furthermore, a significant decrease of SPAG9 level was detected after operation.Conclusion SPAG9 is positively ex-pressed in cervical carcinoma and CIN.A high humoral response against SPAG9 suggests its key role in early detection, clinical diagnosis and postoperative monitoring of cervical carcinoma and CIN patients.
What problem does this paper attempt to address?